MDA-MB-231 cells were used to determine genes differentially regulated by riluzole, a drug currently used to treat ALS patients Overall design: The triple-negative breast cancer cell line, MDA-MB-231,
Improper regulation of translation initiation, a vital check-point of protein synthesis in the cell, has been linked to a number of cancers. Overexpression of protein subunits of eukaryotic translatio
